BSN CAPITAL PARTNERS Ltd decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 68.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,624 shares of the medical equipment provider’s stock after selling 59,376 shares during the quarter. Intuitive Surgical accounts for approximately 1.2% of BSN CAPITAL PARTNERS Ltd’s holdings, making the stock its 8th largest position. BSN CAPITAL PARTNERS Ltd’s holdings in Intuitive Surgical were worth $14,917,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of ISRG. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical during the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical during the first quarter valued at about $30,000. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical during the first quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.
Insiders Place Their Bets
In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Check Out Our Latest Research Report on ISRG
Intuitive Surgical Stock Down 3.2%
NASDAQ:ISRG opened at $429.59 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market capitalization of $154.00 billion, a price-to-earnings ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. The stock has a fifty day simple moving average of $458.68 and a 200 day simple moving average of $497.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the company posted $1.78 EPS. Intuitive Surgical’s revenue for the quarter was up 21.4% on a year-over-year basis. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- What is a support level?
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- Trading Stocks: RSI and Why it’s Useful
- Catch the Next Bitcoin Rally With These 3 ETFs
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.